Journal articles on the topic 'Designer drugs of abuse'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Designer drugs of abuse.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Barone, Joseph A., and Kenneth M. Shermock. "Designer Drugs of Abuse." Journal of Pharmacy Practice 10, no. 4 (1997): 292–300. http://dx.doi.org/10.1177/089719009701000409.
Full textStaack, Roland F. "Piperazine designer drugs of abuse." Lancet 369, no. 9571 (2007): 1411–13. http://dx.doi.org/10.1016/s0140-6736(07)60646-1.
Full textStaack, Roland, and Hans Maurer. "Metabolism of Designer Drugs of Abuse." Current Drug Metabolism 6, no. 3 (2005): 259–74. http://dx.doi.org/10.2174/1389200054021825.
Full textPhan, Stephanie V. "MHC Toolbox: Drugs of abuse." Mental Health Clinician 1, no. 3 (2011): 34–42. http://dx.doi.org/10.9740/mhc.n81014.
Full textSeely, K. A., P. L. Prather, L. P. James, and J. H. Moran. "Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?" Molecular Interventions 11, no. 1 (2011): 36–51. http://dx.doi.org/10.1124/mi.11.1.6.
Full textR. Meyer, Markus, and Hans H. Maurer. "Metabolism of Designer Drugs of Abuse: An Updated Review." Current Drug Metabolism 11, no. 5 (2010): 468–82. http://dx.doi.org/10.2174/138920010791526042.
Full textDumitrescu, F. "Psychosis – Different presentation for designer drugs compared to cannabis abusers?" European Psychiatry 41, S1 (2017): S393. http://dx.doi.org/10.1016/j.eurpsy.2017.02.446.
Full textAiruehia, Efosa, Laine Young Walker, and Jessica Nittler. "A Review of “Bath Salts”: Evolving Designer Drugs of Abuse." Journal of Child & Adolescent Substance Abuse 24, no. 4 (2015): 186–90. http://dx.doi.org/10.1080/1067828x.2013.803942.
Full textde Boer, Douwe, and Ingrid Bosman. "A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs." Pharmacy World & Science 26, no. 2 (2004): 110–13. http://dx.doi.org/10.1023/b:phar.0000018600.03664.36.
Full textZaman, Muhammad, Sobia Razzaq, Rabia Hassan, et al. "Drug abuse among the students." Pakistan Journal of Pharmaceutical Research 1, no. 1 (2015): 41. http://dx.doi.org/10.22200/pjpr.2015141-47.
Full textPourmand, A., P. Armstrong, M. Mazer-Amirshahi, and H. Shokoohi. "The evolving high." Human & Experimental Toxicology 33, no. 10 (2014): 993–99. http://dx.doi.org/10.1177/0960327113514100.
Full textNieddu, Maria, Lucia Burrai, Claudia Trignano, and Gianpiero Boatto. "Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests." Forensic Toxicology 32, no. 1 (2013): 132–38. http://dx.doi.org/10.1007/s11419-013-0198-1.
Full textPawłowska, Beata, and Jolanta Szymańska. "Suicidal ideation, plans, and attempts and the use of psychoactive substances by adolescents." Current Problems of Psychiatry 22, no. 3 (2021): 217–24. http://dx.doi.org/10.2478/cpp-2021-0016.
Full textJohnson, Tonya L., Lois M. Jessen, and Joseph A. Barone. "Trends in Emergency Department Overdose Cases." Journal of Pharmacy Practice 10, no. 4 (1997): 229–34. http://dx.doi.org/10.1177/089719009701000403.
Full textLorenzo Ferreira, R. A., A. M. Ares Fuentes, M. Regenjo Vázquez, A. M. Carro Díaz, A. M. Fernández Sobrino, and P. Férnandez Gómez. "Dispersive liquid–liquid microextraction (DLLME) optimization for determination of designer drugs (cathinones) and drugs abuse in oral fluid." Toxicology Letters 258 (September 2016): S183—S184. http://dx.doi.org/10.1016/j.toxlet.2016.06.1678.
Full textKovács, Katalin, Anita Réka Tóth, and Éva Margit Kereszty. "A new designer drug: Methylone related death." Orvosi Hetilap 153, no. 7 (2012): 271–76. http://dx.doi.org/10.1556/oh.2012.29310.
Full textAweh, Opani, Oniyide Alabi Bello, and Jason Omemu. "A framework for tracking the distribution of increasingly abused pharmaceutical medications." ABUAD International Journal of Natural and Applied Sciences 2, no. 1 (2022): 1–11. http://dx.doi.org/10.53982/aijnas.2022.0201.01-j.
Full textDarie, Iulia-Florentina, Mirela Praisler, and Catalin Negoita. "2C-x and DOx hallucinogens: a systematic review." Annals of the ”Dunarea de Jos” University of Galati Fascicle II Mathematics Physics Theoretical Mechanics 44, no. 1 (2021): 46–52. http://dx.doi.org/10.35219/ann-ugal-math-phys-mec.2021.1.07.
Full textde Boer, Douwe, Ingrid J. Bosman, Elöd Hidvégi, et al. "Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market." Forensic Science International 121, no. 1-2 (2001): 47–56. http://dx.doi.org/10.1016/s0379-0738(01)00452-2.
Full textPérez González, S., M. De Dios Felis, E. Monteagudo Gimeno, et al. "New designer benzodiazepines use in Barcelona." European Psychiatry 41, S1 (2017): S874. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1758.
Full textWelz, Anna, Marcin Koba, Piotr Kośliński, and Joanna Siódmiak. "Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs." Journal of Clinical Medicine 10, no. 24 (2021): 5813. http://dx.doi.org/10.3390/jcm10245813.
Full textMørland, Jørg. "Toxicity of drug abuse — amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use." Toxicology Letters 112-113 (March 2000): 147–52. http://dx.doi.org/10.1016/s0378-4274(99)00217-9.
Full textMohammad, Haneen Talal, and Thamer Abduljabbar Omar. "Abuse Deterrent Dosage Forms: Approaches, Advantages and Limitations." Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 7, no. 2 (2024): 1–7. http://dx.doi.org/10.54133/ajms.v7i2.1277.
Full textJalali, Rakesh, Paula Dmochowska, Izabela Godlewska, et al. "Designers Drugs—A New Challenge to Emergency Departments—An Observational Study in Poland." Medicina 56, no. 7 (2020): 354. http://dx.doi.org/10.3390/medicina56070354.
Full textSchwartz, Richard H., and John P. Morgan. "POINT-COUNTERPOINT." Pediatrics In Review 14, no. 3 (1993): 101–2. http://dx.doi.org/10.1542/pir.14.3.101.
Full textSunshine, I. "Preliminary tests for drugs of abuse." Clinical Chemistry 34, no. 2 (1988): 331–34. http://dx.doi.org/10.1093/clinchem/34.2.324.
Full textPaul, Michael, Josef Ippisch, Christian Herrmann, Susanne Guber, and Wolfgang Schultis. "Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach." Analytical and Bioanalytical Chemistry 406, no. 18 (2014): 4425–41. http://dx.doi.org/10.1007/s00216-014-7825-5.
Full textDearden, John C. "Prediction of Human Lethality of Psychoactive Drugs From Rodent LD50 Values." International Journal of Quantitative Structure-Property Relationships 4, no. 2 (2019): 1–27. http://dx.doi.org/10.4018/ijqspr.2019040101.
Full textNamera, Akira, Kyohei Konuma, Takeshi Saito та ін. "Simple segmental hair analysis for α-pyrrolidinophenone-type designer drugs by MonoSpin extraction for evaluation of abuse history". Journal of Chromatography B 942-943 (грудень 2013): 15–20. http://dx.doi.org/10.1016/j.jchromb.2013.10.021.
Full textIon, Adelina, Mirela Praisler, and Steluta Gosav. "Molecular descriptors – an useful tool for assessing the physico-chemical properties of hallucinogenic drugs of abuse." Annals of the ”Dunarea de Jos” University of Galati Fascicle II Mathematics Physics Theoretical Mechanics 44, no. 1 (2021): 26–29. http://dx.doi.org/10.35219/ann-ugal-math-phys-mec.2021.1.04.
Full textStriebel, Joan M., Emily E. Nelson, and Raj K. Kalapatapu. "“Being with a Buddha”: A Case Report of Methoxetamine Use in a United States Veteran with PTSD." Case Reports in Psychiatry 2017 (2017): 1–4. http://dx.doi.org/10.1155/2017/2319094.
Full textSkaugen, John M., Anthony Scoccimarro, Anthony F. Pizon, et al. "Novel ketamine analogues cause a false positive phencyclidine immunoassay." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 56, no. 5 (2019): 598–607. http://dx.doi.org/10.1177/0004563219858125.
Full textPreve, M., N. E. Suardi, M. Godio, R. Traber, and R. A. Colombo. "Paramethoxymethamphetamine (Mitsubishi turbo) abuse: Case report and literature review." European Psychiatry 41, S1 (2017): s875. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1762.
Full textKumarapeli, Chandani Priyadarshika. "Identification of Cathine in Unknown White Crystalline Substance in Sri Lanka." International Journal of Forensic Sciences 9, no. 1 (2024): 1–8. http://dx.doi.org/10.23880/ijfsc-16000367.
Full textВиноградова, Наталья, Natal'ya Vinogradova, Константин Львов, Konstantin L'vov, Марина Харитонова, and Marina Haritonova. "Prevalence and clinical features of drug-related osteonecroses of the jaws." Actual problems in dentistry 13, no. 4 (2017): 38–42. http://dx.doi.org/10.18481/2077-7566-2017-13-4-38-42.
Full textArroyo, A. "Substance Use among Adolescents in Spain: A Brief Report." Journal of Addiction Medicine and Therapeutic Science 3, no. 1 (2017): 007–10. https://doi.org/10.17352/2455-3484.000019.
Full textBrunetti, Pietro, Raffaele Giorgetti, Adriano Tagliabracci, Marilyn Huestis, and Francesco Busardò. "Designer Benzodiazepines: A Review of Toxicology and Public Health Risks." Pharmaceuticals 14, no. 6 (2021): 560. http://dx.doi.org/10.3390/ph14060560.
Full textMoraru, Monica, Carmen Lidia Chitescu, Aurel Nechita, Luana Andreea Macovei, and Iuliu Fulga. "LC-High-resolution MS Analysis of the Designer Drugs Methylenedioxy-Pyrovalerone (MDPV) and Methylenedioxy-alpha- pyrolidinobutyrophenone (MDPBP) and Their Main Metabolites in Human Urine." Revista de Chimie 69, no. 10 (2018): 2916–020. http://dx.doi.org/10.37358/rc.18.10.6653.
Full textSaefudin, Yusuf, and Gamalel Rifqi Samhudi. "Mencegah Second Victimization Melalui Asesmen Terpadu bagi Korban Penyalahgunaan Narkotika di Kabupaten Banyumas." Kosmik Hukum 21, no. 3 (2021): 159. http://dx.doi.org/10.30595/kosmikhukum.v21i3.12029.
Full textSaefudin, Yusuf, and Gamalel Rifqi Samhudi. "Mencegah Second Victimization Melalui Asesmen Terpadu bagi Korban Penyalahgunaan Narkotika di Kabupaten Banyumas." Kosmik Hukum 21, no. 3 (2021): 159. http://dx.doi.org/10.30595/kosmikhukum.v21i3.12029.
Full textAulia Rahma Sari. "Pertanggungjawaban Pidana bagi Pembuat Drug Design dalam Perspektif Hukum Narkotika." Jurist-Diction 8, no. 1 (2025): 51–76. https://doi.org/10.20473/jd.v8i1.59724.
Full textAldubayyan, Abdulaziz A., Erika Castrignanò, Simon Elliott, and Vincenzo Abbate. "A Quantitative LC–MS/MS Method for the Detection of 16 Synthetic Cathinones and 10 Metabolites and Its Application to Suspicious Clinical and Forensic Urine Samples." Pharmaceuticals 15, no. 5 (2022): 510. http://dx.doi.org/10.3390/ph15050510.
Full textRapaka, Rao S., Vishnudutt Purohit, Paul Schnur, and Joni Rutter. "Emerging trends in the abuse of designer drugs and their catastrophic health effects: Update on chemistry, pharmacology, toxicology and addiction potential." Life Sciences 97, no. 1 (2014): 1. http://dx.doi.org/10.1016/j.lfs.2014.01.074.
Full textKatoch, Madhur, Nitima, and Raj Pathania. "A Cross Sectional Study into Drug Abuse among Youth and Its Association with Socio-demographic and Risk Factors in District Kangra of Himachal Pradesh, India." Asian Journal of Agricultural Extension, Economics & Sociology 41, no. 4 (2023): 141–56. http://dx.doi.org/10.9734/ajaees/2023/v41i41889.
Full textCoppola, M., and R. Mondola. "Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”." Toxicology Letters 211, no. 2 (2012): 144–49. http://dx.doi.org/10.1016/j.toxlet.2012.03.009.
Full textKalapos, Miklós Péter. "3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic?" Orvosi Hetilap 152, no. 50 (2011): 2010–19. http://dx.doi.org/10.1556/oh.2011.29259.
Full textManchikanti, Laxmaiah. "Protocol for Accuracy of Point of Care (POC) or In-Office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)." Pain Physician 1;13, no. 1;1 (2010): E1—E22. http://dx.doi.org/10.36076/ppj.2010/13/e1.
Full textLawan, Mujtaba, and Rebecca Shehu Gabou. "Effect of Solution Focus Therapy on Drugs Abuse Tendency among Addicts of Ndlea Rehabilitation Center, Kano Command, Nigeria." International Journal of Research and Innovation in Social Science VIII, no. VII (2024): 1920–32. http://dx.doi.org/10.47772/ijriss.2024.807151.
Full textFoltin, R. W. "The Importance of Drug Self-Administration Studies in the Analysis of Abuse Liability: An Analysis of Caffeine, Nicotine, Anabolic Steroids, and Designer Drugs." American Journal on Addictions 1, no. 2 (1992): 139–49. http://dx.doi.org/10.3109/10550499209004015.
Full textGameli, Prince Sellase, Johannes Kutzler, Diletta Berardinelli, Jeremy Carlier, Volker Auwärter, and Francesco Paolo Busardò. "Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry." Metabolites 14, no. 9 (2024): 506. http://dx.doi.org/10.3390/metabo14090506.
Full text